Literature DB >> 18835697

Right ventricular involvement in Fabry disease.

Tomas Palecek1, Gabriela Dostalova, Petr Kuchynka, Debora Karetova, Jan Bultas, Milan Elleder, Ales Linhart.   

Abstract

The aim of the study was to describe right ventricular (RV) structural and functional changes in Fabry disease (FD). A detailed echocardiographic examination was performed in 58 patients with proven FD (mean age 40 +/- 16 years, 24 men). RV hypertrophy (RVH) was present in 40% of affected subjects with similar prevalence in both genders. Approximately two thirds of patients with left ventricular hypertrophy (LVH) also exhibited RVH. RV dilatation was not present in any subject. RV systolic dysfunction was noted in only 1 female subject. RV diastolic dysfunction was present in 47% of 45 subjects in whom RV filling was assessed. RV diastolic dysfunction was associated with the presence of RVH. A significant correlation between RV wall thickness and age (r = 0.52, P < .001) and left ventricular mass index (r = 0.70, P < .001) was noted. RVH with normal chamber size and preserved systolic but impaired diastolic function represents a typical RV structural change in FD. Its prevalence and degree are related to the prevalence and degree of LVH and the age of the patient.

Entities:  

Mesh:

Year:  2008        PMID: 18835697     DOI: 10.1016/j.echo.2008.09.002

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  9 in total

1.  Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status.

Authors:  Daniel A Morris; Daniela Blaschke; Sima Canaan-Kühl; Alice Krebs; Gesine Knobloch; Thula C Walter; Wilhelm Haverkamp
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-15       Impact factor: 2.357

Review 2.  Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations.

Authors:  Aleš Linhart; Tomáš Paleček
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 3.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

4.  Reduced Right Ventricular Native Myocardial T1 in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls.

Authors:  Joseph J Pagano; Kelvin Chow; Aneal Khan; Evangelos Michelakis; Ian Paterson; Gavin Y Oudit; Richard B Thompson
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

5.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.

Authors:  Elisabeth Fabian; Dietmar Schiller; Hermann Toplak; Michaela Brunner-Krainz; Franz Fazekas; Rainer Schoefl; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2017-11-21       Impact factor: 1.704

6.  Prognostic significance of right ventricular hypertrophy and systolic function in Anderson-Fabry disease.

Authors:  Francesca Graziani; Rosa Lillo; Elena Panaioli; Maurizio Pieroni; Antonia Camporeale; Elena Verrecchia; Ludovico Luca Sicignano; Raffaele Manna; Antonella Lombardo; Gaetano Antonio Lanza; Filippo Crea
Journal:  ESC Heart Fail       Date:  2020-05-20

Review 7.  Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring.

Authors:  Björn Hoffmann
Journal:  Orphanet J Rare Dis       Date:  2009-10-11       Impact factor: 4.123

Review 8.  Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future.

Authors:  Roberta Esposito; Ciro Santoro; Giulia Elena Mandoli; Vittoria Cuomo; Regina Sorrentino; Lucia La Mura; Maria Concetta Pastore; Francesco Bandera; Flavio D'Ascenzi; Alessandro Malagoli; Giovanni Benfari; Antonello D'Andrea; Matteo Cameli
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

Review 9.  Anderson-Fabry disease in heart failure.

Authors:  M M Akhtar; P M Elliott
Journal:  Biophys Rev       Date:  2018-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.